Histopathological characterization of ductal carcinoma in situ (DCIS) of the breast according to HER2 amplification status and molecular subtype.

MLA

Van Bockstal, Mieke, et al. “Histopathological Characterization of Ductal Carcinoma in Situ (DCIS) of the Breast According to HER2 Amplification Status and Molecular Subtype.” Virchows Archiv : An International Journal of Pathology, vol. 465, no. 3, Sept. 2014, pp. 275–89. EBSCOhost, https://doi.org/10.1007/s00428-014-1609-3.

APA

Van Bockstal, M., Lambein, K., Denys, H., Braems, G., Nuyts, A., Van den Broecke, R., Cocquyt, V., De Wever, O., & Libbrecht, L. (2014). Histopathological characterization of ductal carcinoma in situ (DCIS) of the breast according to HER2 amplification status and molecular subtype. Virchows Archiv : An International Journal of Pathology, 465(3), 275–289. https://doi.org/10.1007/s00428-014-1609-3

Chicago

Van Bockstal, Mieke, Kathleen Lambein, Hannelore Denys, Geert Braems, Ann Nuyts, Rudy Van den Broecke, Veronique Cocquyt, Olivier De Wever, and Louis Libbrecht. 2014. “Histopathological Characterization of Ductal Carcinoma in Situ (DCIS) of the Breast According to HER2 Amplification Status and Molecular Subtype.” Virchows Archiv : An International Journal of Pathology 465 (3): 275–89. doi:10.1007/s00428-014-1609-3.